
Akumin AKU
Quarterly report 2023-Q3
added 12-12-2023
Akumin P/E Ratio 2011-2026 | AKU
Annual P/E Ratio Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.479 | -1.92 | -10.8 | 48.2 | 51.2 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 51.2 | -10.8 | 17.2 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 1.48 | -9.51 % | $ 1.97 M | ||
|
Castle Biosciences
CSTL
|
-19.5 | $ 18.95 | 0.4 % | $ 549 M | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 15.85 | -2.1 % | $ 479 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 18.56 | - | $ 196 M | ||
|
Agilent Technologies
A
|
34.7 | $ 112.0 | -1.1 % | $ 34 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 20.15 | -1.66 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 95.11 | -1.61 % | $ 6.42 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 417.38 | -0.43 % | $ 12 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 036.33 | -0.53 % | $ 21.4 B | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 3.63 | 0.14 % | $ 336 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
-13.7 | $ 8.31 | -0.6 % | $ 1.06 B | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 158.4 | -0.56 % | $ 7.85 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
National Research Corporation
NRC
|
27.2 | $ 18.87 | -0.3 % | $ 422 M | ||
|
Natera
NTRA
|
-9.69 | $ 191.02 | -2.99 % | $ 18.8 B | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
33.8 | $ 25.35 | -0.63 % | $ 24 B | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
-32.3 | $ 96.33 | -2.36 % | $ 12.1 B | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 5.71 | -1.89 % | $ 238 M | ||
|
Personalis
PSNL
|
-5.3 | $ 6.55 | -2.38 % | $ 585 M | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 115.8 | -1.11 % | $ 9.55 B | ||
|
Illumina
ILMN
|
-13.4 | $ 139.62 | -2.53 % | $ 22.2 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Trinity Biotech plc
TRIB
|
-6.21 | $ 0.58 | -0.63 % | $ 208 M | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.42 | 0.41 % | $ 5.56 M | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 50.69 | -4.27 % | $ 3.03 B | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 439.8 | -1.86 % | $ 166 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 253.87 | -0.09 % | $ 21.1 B | ||
|
Celcuity
CELC
|
-30.3 | $ 133.09 | -1.21 % | $ 6.22 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
30.6 | $ 329.45 | -1.15 % | $ 19.6 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 8.39 | -0.47 % | $ 1.82 B |